Car T Cells Secreting an Immune Checkpoint Blockade scFv Have Enhanced Anti-Tumor Efficacy

被引:0
|
作者
Rafiq, Sarwish [1 ]
Yeku, Oladapo [1 ]
Jackson, Hollie [1 ]
Purdon, Terence [1 ]
van Leeuwen, Dayenne [1 ]
Yan, Su [2 ]
Wang, Pei [2 ]
Xiang, Jingyi [2 ]
Liu, Cheng [2 ]
Brentjens, Renier [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Eureka Therapeut, Emeryville, CA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
966
引用
收藏
页码:439 / 440
页数:2
相关论文
共 50 条
  • [1] CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy
    Rafiq, Sarwish
    Yeku, Oladapo
    Jackson, Hollie
    Purdon, Terence
    van Leeuwen, Dayenne
    Yan, Su
    Wang, Pei
    Xiang, Jingyi
    Liu, Cheng
    Seshan, Venkatraman
    Brentjens, Renier
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Enhancing CAR T Cell Anti-Tumor Efficacy through Secreted Single Chain Variable Fragment (scFv) Immune Checkpoint Blockade
    Rafiq, Sarwish
    Jackson, Hollie J.
    Yeku, Oladapo
    Purdon, Terence J.
    van Leeuwen, Dayenne G.
    Curran, Kevin J.
    Ahmed, Ryan N.
    Cullen, Grace D.
    Yan, Su
    Wang, Pei
    Xiang, Jingyi
    Liu, Cheng
    Brentjens, Renier J.
    BLOOD, 2017, 130
  • [3] Dynamic Mechanisms of Immune Checkpoint Blockade for Controlling Anti-Tumor T Cells in Immune Microenvironments
    Ono, Masahiro
    Hassan, Jehanne
    Appleton, Elizabeth
    Pedersen, Malin
    Foo, Shane
    Reda, Omnia
    Satou, Yorifumi
    Okazaki, Il-Mi
    Okazaki, Taku
    Harrington, Kevin
    Melcher, Alan
    CANCER SCIENCE, 2025, 116 : 709 - 709
  • [4] Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
    Redmond, William L.
    Kasiewicz, Melissa J.
    Akporiaye, Emmanuel T.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] ENHANCEMENT OF ANTI-TUMOR EFFICACY OF IMMUNE CHECKPOINT BLOCKADE BY ALPHATOCOPHERYLOXACETIC ACID-LYSINE
    Akporiaye, Emmanuel
    Redmond, William
    Kasiewicz, Melissa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A838 - A838
  • [6] Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system
    Xiaohui Wang
    Zhiqiang Wu
    Wei Qiu
    Ping Chen
    Xiang Xu
    Weidong Han
    Frontiers of Medicine, 2020, 14 : 726 - 745
  • [7] Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system
    Wang, Xiaohui
    Wu, Zhiqiang
    Qiu, Wei
    Chen, Ping
    Xu, Xiang
    Han, Weidong
    FRONTIERS OF MEDICINE, 2020, 14 (06) : 726 - 745
  • [8] Talilmogene laherparepvec increases the anti-tumor efficacy of the anti PD-1 immune checkpoint blockade
    Piasecki, Julia
    Le, Tiep
    Ponce, Rafael
    Beers, Courtney
    CANCER RESEARCH, 2015, 75
  • [9] ROLE OF CAR EXPRESSION LEVELS IN THE ANTI-TUMOR EFFICACY OF CAR-T CELLS
    Rodriguez-Marquez, P.
    Calleja-Cervantes, M. E.
    Serrano, G.
    San Martin-Uriz, P.
    Vilas-Zornoza, A.
    Martin-Mallo, A.
    Rodriguez-Diaz, S.
    Martinez-Turrillas, R.
    Jauregui, P.
    Calvino, C.
    Inoges, S.
    Lopez-Diaz, de Cerio A.
    Palacios-Berraquero, M. L.
    Rodriguez-Otero, P.
    Rifon, J.
    Alfonso, A.
    Lasarte, J. J.
    Lozano, T.
    Hernaez, M.
    Rodriguez-Madoz, J. R.
    Prosper, F.
    HAEMATOLOGICA, 2021, 106 (10) : 58 - 59
  • [10] Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
    Rafiq, Sarwish
    Yeku, Oladapo O.
    Jackson, Hollie J.
    Purdon, Terence J.
    van Leeuwen, Dayenne G.
    Drakes, Dylan J.
    Song, Mei
    Miele, Matthew M.
    Li, Zhuoning
    Wang, Pei
    Yan, Su
    Xiang, Jingyi
    Ma, Xiaojing
    Seshan, Venkatraman E.
    Hendrickson, Ronald C.
    Liu, Cheng
    Brentjens, Renier J.
    NATURE BIOTECHNOLOGY, 2018, 36 (09) : 847 - +